Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymopentin for Prevention of Recurrence in Small HCC After Resection
NCT00460681Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Feb 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thymopentin in hepatocellular carcinoma (HCC), sponsored by Fudan University. Status: unknown.
02
Drugs
thymopentin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00460681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460681.